Vitamin K to reverse excessive anticoagulation

A review of the literature

Charles Thomas Taylor, Elizabeth A. Chester, Debbie C. Byrd, Mark A. Stephens

Research output: Contribution to journalReview articleResearchpeer-review

30 Citations (Scopus)

Abstract

We conducted an extensive literature review to evaluate the appropriate use, route, and dose of vitamin K to reverse excessive anticoagulation. Issues such as sample size, study design, different patient populations, and various study end points confounded results. Of 18 studies published, 8 enrolled 229 patients to evaluate parenteral vitamin K administration. Nine studies with 288 patients evaluated oral administration, and only 2 retrospective studies (280 patients) compared routes of administration. Reductions in international normalized ratios at 24 hours ranged from 21-42%, 47-86%, 25-67%, and 40-75% for temporary warfarin discontinuation alone, and intravenous, subcutaneous, and oral routes of vitamin K administration, respectively. Methodologically weak studies and indeterminate results plague interpretation of the literature on vitamin K. In general, results of this review support current guidelines for reversing excessive warfarin anticoagulation. However, it is important to realize that the quality of literature on which these recommendations are based is poor and that optimal dose and route of vitamin K administration remain unclear. Large, well- designed, randomized, controlled trials are necessary to define optimum management strategies for excessively anticoagulated patients.

Original languageEnglish
Pages (from-to)1415-1425
Number of pages11
JournalPharmacotherapy
Volume19
Issue number12
DOIs
StatePublished - 1 Jan 1999

Fingerprint

Vitamin K
Warfarin
International Normalized Ratio
Plague
Sample Size
Oral Administration
Randomized Controlled Trials
Retrospective Studies
Guidelines
Population

Cite this

Taylor, Charles Thomas ; Chester, Elizabeth A. ; Byrd, Debbie C. ; Stephens, Mark A. / Vitamin K to reverse excessive anticoagulation : A review of the literature. In: Pharmacotherapy. 1999 ; Vol. 19, No. 12. pp. 1415-1425.
@article{a4e370353ae441db97b3a925438bc4ad,
title = "Vitamin K to reverse excessive anticoagulation: A review of the literature",
abstract = "We conducted an extensive literature review to evaluate the appropriate use, route, and dose of vitamin K to reverse excessive anticoagulation. Issues such as sample size, study design, different patient populations, and various study end points confounded results. Of 18 studies published, 8 enrolled 229 patients to evaluate parenteral vitamin K administration. Nine studies with 288 patients evaluated oral administration, and only 2 retrospective studies (280 patients) compared routes of administration. Reductions in international normalized ratios at 24 hours ranged from 21-42{\%}, 47-86{\%}, 25-67{\%}, and 40-75{\%} for temporary warfarin discontinuation alone, and intravenous, subcutaneous, and oral routes of vitamin K administration, respectively. Methodologically weak studies and indeterminate results plague interpretation of the literature on vitamin K. In general, results of this review support current guidelines for reversing excessive warfarin anticoagulation. However, it is important to realize that the quality of literature on which these recommendations are based is poor and that optimal dose and route of vitamin K administration remain unclear. Large, well- designed, randomized, controlled trials are necessary to define optimum management strategies for excessively anticoagulated patients.",
author = "Taylor, {Charles Thomas} and Chester, {Elizabeth A.} and Byrd, {Debbie C.} and Stephens, {Mark A.}",
year = "1999",
month = "1",
day = "1",
doi = "10.1592/phco.19.18.1415.30896",
language = "English",
volume = "19",
pages = "1415--1425",
journal = "Pharmacotherapy",
issn = "0277-0008",
publisher = "Wiley-Blackwell",
number = "12",

}

Vitamin K to reverse excessive anticoagulation : A review of the literature. / Taylor, Charles Thomas; Chester, Elizabeth A.; Byrd, Debbie C.; Stephens, Mark A.

In: Pharmacotherapy, Vol. 19, No. 12, 01.01.1999, p. 1415-1425.

Research output: Contribution to journalReview articleResearchpeer-review

TY - JOUR

T1 - Vitamin K to reverse excessive anticoagulation

T2 - A review of the literature

AU - Taylor, Charles Thomas

AU - Chester, Elizabeth A.

AU - Byrd, Debbie C.

AU - Stephens, Mark A.

PY - 1999/1/1

Y1 - 1999/1/1

N2 - We conducted an extensive literature review to evaluate the appropriate use, route, and dose of vitamin K to reverse excessive anticoagulation. Issues such as sample size, study design, different patient populations, and various study end points confounded results. Of 18 studies published, 8 enrolled 229 patients to evaluate parenteral vitamin K administration. Nine studies with 288 patients evaluated oral administration, and only 2 retrospective studies (280 patients) compared routes of administration. Reductions in international normalized ratios at 24 hours ranged from 21-42%, 47-86%, 25-67%, and 40-75% for temporary warfarin discontinuation alone, and intravenous, subcutaneous, and oral routes of vitamin K administration, respectively. Methodologically weak studies and indeterminate results plague interpretation of the literature on vitamin K. In general, results of this review support current guidelines for reversing excessive warfarin anticoagulation. However, it is important to realize that the quality of literature on which these recommendations are based is poor and that optimal dose and route of vitamin K administration remain unclear. Large, well- designed, randomized, controlled trials are necessary to define optimum management strategies for excessively anticoagulated patients.

AB - We conducted an extensive literature review to evaluate the appropriate use, route, and dose of vitamin K to reverse excessive anticoagulation. Issues such as sample size, study design, different patient populations, and various study end points confounded results. Of 18 studies published, 8 enrolled 229 patients to evaluate parenteral vitamin K administration. Nine studies with 288 patients evaluated oral administration, and only 2 retrospective studies (280 patients) compared routes of administration. Reductions in international normalized ratios at 24 hours ranged from 21-42%, 47-86%, 25-67%, and 40-75% for temporary warfarin discontinuation alone, and intravenous, subcutaneous, and oral routes of vitamin K administration, respectively. Methodologically weak studies and indeterminate results plague interpretation of the literature on vitamin K. In general, results of this review support current guidelines for reversing excessive warfarin anticoagulation. However, it is important to realize that the quality of literature on which these recommendations are based is poor and that optimal dose and route of vitamin K administration remain unclear. Large, well- designed, randomized, controlled trials are necessary to define optimum management strategies for excessively anticoagulated patients.

UR - http://www.scopus.com/inward/record.url?scp=0032711231&partnerID=8YFLogxK

U2 - 10.1592/phco.19.18.1415.30896

DO - 10.1592/phco.19.18.1415.30896

M3 - Review article

VL - 19

SP - 1415

EP - 1425

JO - Pharmacotherapy

JF - Pharmacotherapy

SN - 0277-0008

IS - 12

ER -